title: [Effectiveness of imatinib mesylate in treatment for dermatofibroma protuberans].
authors.forename: V M
authors.initials: VM
authors.lastname: Moiseenko
authors.forename: V A
authors.initials: VA
authors.lastname: Chudenko
authors.forename: R V
authors.initials: RV
authors.lastname: Orlova
authors.forename: E N
authors.initials: EN
authors.lastname: Imianitov
authors.forename: D E
authors.initials: DE
authors.lastname: Matsko
authors.forename: G I
authors.initials: GI
authors.lastname: Gafton
authors.forename: V A
authors.initials: VA
authors.lastname: Kochnev
authors.forename: S A
authors.initials: SA
authors.lastname: Protsenko
authors.forename: T D
authors.initials: TD
authors.lastname: Mikhaĭlichenko
authors.forename: T Kh
authors.initials: TKh
authors.lastname: Nogaeva
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D018223:Dermatofibrosarcoma / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases